Literature DB >> 901702

Amphetamines, growth hormone and narcolepsy.

J D Parkes, A G Debono, P Jenner, J Walters.   

Abstract

1 Plasma amphetamine and growth hormone levels have been measured in eight normal and twenty-six narcoleptic subjects following a single dose of (+)-amphetamine (20 mg) or (-)-amphetamine (20 mg) by mouth. 2 Peak plasma levels and the shape of the plasma amphetamine-time curve were similar with both isomers in normal and narcoleptic subjects. 3 In most normal subjects both (+)-and (-)-amphetamine (20 mg) caused an increase in the plasma concentration of growth hormone. The two isomers were approximately equipotent in this respect. Neither (+)- nor (-)-amphetamine (20 mg) caused an increase in plasma growth hormone concentration in narcoleptics. 4 Following amphetamine (30 mg), two of six narcoleptic subjects had an increase in plasma growth hormone concentration. 5 Levodopa (250 mg) with (-)-alpha-methyldopa hydrazine 25 mg (Sinemet) by mouth, caused a rise in plasma growth hormone concentration in most normal subjects. The magnitude of the Sinemet-induced rise in plasma growth hormone concentration in narcoleptics was less than in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 901702      PMCID: PMC1429067          DOI: 10.1111/j.1365-2125.1977.tb00722.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA.

Authors:  D S SCHALCH; M L PARKER
Journal:  Nature       Date:  1964-09-12       Impact factor: 49.962

2.  INFLUENCE OF URINARY PH ON EXCRETION OF AMPHETAMINE.

Authors:  A H BECKETT; M ROWLAND; P TURNER
Journal:  Lancet       Date:  1965-02-06       Impact factor: 79.321

3.  [Changes of plasma growth hormone level in normal and hypersomnic patients during nocturnal sleep].

Authors:  K Takahashi; S Takahashi; K Azumi; Y Honda; H Utena
Journal:  Shinkei Kenkyu No Shimpo       Date:  1971-04

4.  The importance of endogenous catecholamines in the activity of some CNS stimulants.

Authors:  H H Wolf; D E Rollins; C R Rowland; T G Reigle
Journal:  Int J Neuropharmacol       Date:  1969-07

5.  Adrenergic blockade and the corticosteroid and growth hormone responses to methylamphetamine.

Authors:  L Rees; P W Butler; C Gosling; G M Besser
Journal:  Nature       Date:  1970-11-07       Impact factor: 49.962

6.  Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.

Authors:  B S Bunney; G K Aghajanian; R H Roth
Journal:  Nat New Biol       Date:  1973-09-26

7.  A note on the effect of (+)- and (-)-amphetamine on lipid metabolism.

Authors:  G T Hajos; S Garattini
Journal:  J Pharm Pharmacol       Date:  1973-05       Impact factor: 3.765

8.  Psychopharmacology of amphetamines.

Authors:  J M van Rossum
Journal:  Psychiatr Neurol Neurochir       Date:  1972 May-Jun

9.  Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.

Authors:  J D Parkes; G W Fenton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-12       Impact factor: 10.154

10.  Influence of amphetamines on plasma corticosteroid and growth hormone levels in man.

Authors:  G M Besser; P W Butler; J Landon; L Rees
Journal:  Br Med J       Date:  1969-11-29
View more
  1 in total

Review 1.  Neuroendocrine markers of CNS drug effects.

Authors:  E C Johnstone; I N Ferrier
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.